SCHEMBL7723181

SCHEMBL7723181

Cc1ccc(S(=O)(=O)OCC2CCc3ccccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
HTR6 P50406 3/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HTT P42858 1/20 0.41
PSEN1 P49768 2/20 0.40
PSEN2 P49810 2/20 0.40
APH1B Q8WW43 2/20 0.40
NCSTN Q92542 2/20 0.40
APH1A Q96BI3 2/20 0.40
PSENEN Q9NZ42 2/20 0.40
CRBN Q96SW2 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7725242 0.93 ALDH1A1 (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL8344592 0.88 ALDH1A1 (0.46) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL8639499 0.87 ALDH1A1 (0.43) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL6978852 0.82 CA2 (0.45) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL14143008 0.82 CA2 (0.45) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL9722171 0.79 MEN1 (0.53) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL8744413 0.79 IDO1 (0.47) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL9466306 0.78 ALDH1A1 (0.44) ALDH1A1LMNAMAPTRECQLHTR6
SCHEMBL7719725 0.78 PSEN1 (0.46) ALDH1A1LMNACA1CA2PSEN1
SCHEMBL7723979 0.77 PSEN1 (0.47) ALDH1A1LMNAHTTPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed